ORTINLABSS

Members of the Exchange are hereby informed that the trading in Equity Shares of Ortin Laboratories Limited shall be suspended w.e.f. January 12, 2021 on account of Scheme of Arrangement - Demerger and Capital Reduction

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response.

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response.

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response.

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

ORTINLABSS:The Exchange had sought clarification from Ortin Laboratories Limited with respect to announcement dated 27-Apr-2018, regarding " Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on April 27, 2018.".On basis of above the Company is required to clarify following:1. Disclosure of relationships between directors (in case of appointment of a director).<br>The response of the Company is enclosed.

ORTINLABSS:The Exchange has sought clarification from Ortin Laboratories Limited with respect to announcement dated 27-Apr-2018, regarding " Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on April 27, 2018.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director).<br> The response of the Company is awaited.

Significant increase in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response.

Significant increase in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

Clarification by Ortin Laboratories LimitedSignificant price movement has been observed in Ortin Laboratories Limited.The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company.Ortin Laboratories Limitedhas vide its letter inter-alia stated, "With reference to the subject cited, we wish to clarify that there is no any specific information or announcement including pending announcement with the Company which in turn may have bearing on the price